Sagimet Biosciences Inc.
SGMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $42 | $65 | $76 |
| Short-Term Investments | $84 | $83 | $80 | $75 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $2 | $2 |
| Total Curr. Assets | $119 | $127 | $146 | $153 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $9 | $10 | $0 | $7 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $9 | $10 | $0 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $128 | $137 | $146 | $160 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $3 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $5 | $4 | $3 |
| Total Curr. Liab. | $9 | $7 | $7 | $4 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $7 | $7 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$337 | -$324 | -$313 | -$295 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $456 | $454 | $452 | $451 |
| Total Equity | $119 | $130 | $139 | $156 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $128 | $137 | $146 | $160 |
| Net Debt | -$32 | -$42 | -$65 | -$76 |